Trump Says He Doesn’t ‘Give A Damn’ About Gas Prices As US Making ‘Fortune’
Technocracy Takeover. Musk is Fabulously Wealthy, Politically Aggressive, Erratic, and Accountable to no one
Jim Crow Returns…One Congressional District at a Time
American Voters Generally Expect the Upcoming Midterm Elections Across the Country to be run and Administered Well, Have Confidence That Election Workers Will Handle Ballots Securely, and say the Outcome Will be Clear After all the Ballots are Counted
U.S. Allies Race to Escape Spacex’s Orbit. Elon Musk’s Blindsiding of Ukraine Spurs Efforts by Europe and Canada to Roll out Satellites Under Their own Control
Musk Said on Saturday That his Company Spacex had Throttled the Starlink Satellite Internet Service in Ukraine
Portal Texas Used to ‘Rubber Stamp’ Data Centers Down After 404 Media Reporting
Brazil Elections: How AI, Meta and Evangelicals Could Sway the Presidential Race for Bolsonaro
The Starlink-Ukraine Scandal, Phase 2. The Case for Taking Control Away From Musk Gets Even Stronger
Meta Delays Rollout of Terms That Would Allow Broad Scraping of News Sites. Legal Experts are Still Skeptical
Trump Says He Doesn’t ‘Give A Damn’ About Gas Prices As US Making ‘Fortune’
Technocracy Takeover. Musk is Fabulously Wealthy, Politically Aggressive, Erratic, and Accountable to no one
Jim Crow Returns…One Congressional District at a Time
American Voters Generally Expect the Upcoming Midterm Elections Across the Country to be run and Administered Well, Have Confidence That Election Workers Will Handle Ballots Securely, and say the Outcome Will be Clear After all the Ballots are Counted
U.S. Allies Race to Escape Spacex’s Orbit. Elon Musk’s Blindsiding of Ukraine Spurs Efforts by Europe and Canada to Roll out Satellites Under Their own Control
Musk Said on Saturday That his Company Spacex had Throttled the Starlink Satellite Internet Service in Ukraine
Portal Texas Used to ‘Rubber Stamp’ Data Centers Down After 404 Media Reporting
Brazil Elections: How AI, Meta and Evangelicals Could Sway the Presidential Race for Bolsonaro
The Starlink-Ukraine Scandal, Phase 2. The Case for Taking Control Away From Musk Gets Even Stronger
Meta Delays Rollout of Terms That Would Allow Broad Scraping of News Sites. Legal Experts are Still Skeptical

Penn STEM Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Penn STEM Times.

August 2026

September 2026

October 2026

Press releases published on October 26, 2026

JoyThriveCare Introduces Voice-Enabled Smart Home Solution Designed for Senior Living

26 minutes ago

JoyThriveCare Introduces Voice-Enabled Smart Home Solution Designed for Senior Living

EIN Presswire

Initta Technology Showcases Smart Retail & Food Service Ecosystem in London

an hour ago

Initta Technology Showcases Smart Retail & Food Service Ecosystem in London

GlobeNewswire

North Vector Dynamics Closes Series A Exceeding USD $20 Million, One of Canada’s Largest Defence Technology Financings

an hour ago

North Vector Dynamics Closes Series A Exceeding USD $20 Million, One of Canada’s Largest Defence Technology Financings

GlobeNewswire

Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress

an hour ago

Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress

GlobeNewswire

BioNTech und DualityBio geben Topline-Ergebnisse der globalen klinischen Phase-3-Studie DYNASTY-Breast02 für Trastuzumab Pamirtecan bei metastasiertem HR+/HER2-low-Brustkrebs bekannt

2 hours ago

BioNTech und DualityBio geben Topline-Ergebnisse der globalen klinischen Phase-3-Studie DYNASTY-Breast02 für Trastuzumab Pamirtecan bei metastasiertem HR+/HER2-low-Brustkrebs bekannt

GlobeNewswire

BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer

2 hours ago

BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer

GlobeNewswire

CoinW Partners with EngageLab to Fortify Global Trading Communications

2 hours ago

CoinW Partners with EngageLab to Fortify Global Trading Communications

GlobeNewswire

HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026

3 hours ago

HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026

GlobeNewswire

Phathom Pharmaceuticals Provides Update on FDA Litigation

3 hours ago

Phathom Pharmaceuticals Provides Update on FDA Litigation

GlobeNewswire

Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026

4 hours ago

Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026

GlobeNewswire

HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine

11 hours ago

HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine

GlobeNewswire